Processa Pharmaceuticals, Inc.: Form 8-K, filed May 26, 2021
Filed with the SEC on May 26, 2021 and accepted by EDGAR at May 26, 2021, 06:15 ET.
Items reported
- Item 1.02 Termination of a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-21-012907. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.